Translating Advanced Neuroimaging into Routine Clinical Practice at NeuroRAD 2026
Ahead of the neuroRAD 2026 congress in Mainz, congress president Dr. Katharina Wenger-Alakmeh discussed the advanced imaging techniques featured in this year’s abstracts, the persistent barriers to clinical translation, and which quantitative MRI methods are moving into daily use, AuntMinnieEurope reported. The conference highlights a growing emphasis on concrete clinical questions, particularly in tumor characterization, margin delineation, and deep-learning image reconstruction.
Abstract Program Highlights Tumor Imaging and Deep-Learning Reconstruction
The abstract program for the upcoming congress features a strong translational focus centered on advanced MRI techniques such as chemical exchange saturation transfer (CEST), diffusion imaging, and multiparametric quantitative imaging. Wenger-Alakmeh noted that much of this work addresses tumor characterization, progression tracking, and the precise delineation of tumor margins for infiltrative types. Beyond oncology, abstract highlights include a study from Freiburg evaluating whether deep-learning reconstruction increases sensitivity for very small lesions compared with standard imaging, alongside multiple contributions exploring foundation models from Bonn.
Three-Step Breakdown Hinders Clinical Translation of Imaging Biomarkers
Despite promising biomarkers, translation into routine care frequently stalls across three distinct operational hurdles. Wenger-Alakmeh identified acquisition as the first barrier, pointing out that MRI technologies and hardware manufacturers lack full harmonization for multiparametric quantitative techniques and spectroscopy quantification. To counter this, a project originating in Frankfurt alongside 12 other German centers developed a reproducible, cross-vendor eight-minute protocol designed to run alongside standard clinical routines.
The subsequent bottlenecks involve standardizing postprocessing and analysis on a common automated platform, establishing rigorous biological validation, and proving prospectively that these biomarkers actively alter clinical decision-making.
Routine Clinical Adoption Varies Across Quantitative MRI Methods
Perfusion imaging and diffusion imaging with apparent diffusion coefficient (ADC) maps have successfully transitioned into daily practice for tumor and stroke evaluations. Proton spectroscopy remains useful for selected clinical questions, though quantification continues to vary across different hardware manufacturers. Automated volumetry and lesion quantification are also established in routine care for managing tumors, multiple sclerosis, and neurodegenerative diseases. Meanwhile, APT-CEST is gaining momentum as product sequences become available, whereas relaxometry mapping, sodium imaging, and multinuclear imaging largely remain in the research domain.
Generational Change and Mentorship Drive the NeuroRAD 2026 Agenda
Organizers of neuroRAD 2026 structured the event around a three-person leadership model that pairs younger chairs with experienced mentors across various conference formats. This intentional generational shift aims to establish durable professional connections and provide junior radiologists with accessible guidance. The program also incorporates protected spaces and dedicated formats addressing the specific professional needs of women in neuroradiology and the broader early-career community.
Frequently Asked Questions About NeuroRAD 2026 Innovations
Where is neuroRAD 2026 taking place?
The congress is scheduled to take place in Mainz.
Who are the congress presidents for the event?
The leadership team consists of Dr. Roland Schwab based in Magdeburg, Dr. Katharina Wenger-Alakmeh from Frankfurt am Main, and Dr. Daniel Kaiser based in Dresden.
Which institution led the multi-center protocol project for quantitative MRI?
The project was initiated in Frankfurt in collaboration with 12 other centers across Germany to establish a reproducible eight-minute scanning protocol.
What specific AI applications were highlighted in the abstract submissions?
Submissions featured a Freiburg study examining deep-learning reconstruction for small lesion sensitivity and multiple foundation model studies originating from Bonn.
Related reading